𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A 26-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma

✍ Scribed by Figliomeni, M.; Kianifard, F.; Meng, X.


Book ID
119284505
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
45 KB
Volume
127
Category
Article
ISSN
1097-6825

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Efficacy, tolerability, and effect on as